Best Clinical Practice Support Services

Welcome to the Care Transitions Network’s Best Clinical Practice Support Services!

The Care Transitions Network aims to decrease all-cause re-hospitalization rates among people with serious mental illness (SMI) by 50%. Care Transitions Network subject matter experts at Northwell Health can support your organization to achieve this goal through free on-site or virtual trainings focused on improving clinical practices in screening, diagnosis, treatment and management of patients with SMI. CEUs are now available to LCSWs for nine of the trainings.

Select the training title to learn more or contact CareTransitions@TheNationalCouncil.org to schedule a training.

Education and Training Service Menu

General

DIAGNOSIS OF PSYCHOTIC DISORDERS

This training reviews the importance of accurate diagnosis for treatment planning and key features that define psychotic symptoms. Participants will leave with interview techniques to elicit these key features and how to use this knowledge to diagnose psychotic disorders using DSM-V criteria. This training is typically held in three sessions, but can be adapted accordingly.

Intended Audience: Clinicians

CEU Credit(s): Three (3) available for LCSWs, LCSW-Rs and LMSWs

DIAGNOSING COMORBIDITY

Accurate diagnosis and documentation of psychiatric comorbidity promotes improved patient outcomes and appropriate reimbursement; however, comorbidities are often underdiagnosed. This training focuses on approaches for accurate identification and diagnosis of two or more psychiatric disorders. Training includes exploration of case examples and exposure to standardized probes during an intake interview to increase the chance of diagnosing co-occurring disorders.

Intended Audience: Prescribers, other clinicians

CEU Credit(s): One (1) available for LCSWs, LCSW-Rs and LMSWs

ELECTROCONVULSIVE THERAPY AS AN EFFECTIVE TREATMENT FOR PSYCHOSIS

Electroconvulsive Therapy (ECT) is a treatment option for severe and persistent psychiatric disorders. ECT is often considered a treatment of last resort, but for certain conditions is appropriate as an earlier treatment option. This training reviews ECT, dispels common myths surrounding this effective treatment option, and discusses the practical considerations for clinicians to appropriately recommend ECT to their clients to promote improved health outcomes.

Intended Audience: Clinicians

CEU Credit(s): One (1) available for LCSWs, LCSW-Rs and LMSWs

Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second-Generation Antipsychotics

People with Schizophrenia die decades earlier due to preventable medical illness. Signs of medical illness present early, but medical care is often suboptimal. Second-generation antipsychotics (SGAs) contribute to risk factors, but more metabolic monitoring is needed, not less SGA utilization. This training reviews guidelines for monitoring adverse metabolic effects and recommendations for treatment/medical referral. Training includes review of current guidelines and recommendations to implement a successful metabolic monitoring program at your facility.

Intended Audience: Administrators, prescribers, other clinicians

CEU Credit(s): One (1) available for LCSWs, LCSW-Rs and LMSWs

Identification and Brief Treatment Approaches for Substance Use Disorders

Substance abuse has been shown in many studies to be a risk factor for medication non-adherence, hospital admission and poor health outcomes. It is estimated that Substance Use Disorders (SUD) have a U.S. societal cost of approximately $276 billion per year, which includes lost productivity and added healthcare costs. This training provides an overview of substance use, interview techniques to differentiate psychotic disorders with comorbid substance use and substance-induced psychotic disorders, and current treatment approaches for substance use disorders.

Intended Audience: Clinicians

CEU Credit(s): One (1) available for LCSWs, LCSW-Rs and LMSWs

WHAT TEAM MEMBERS OTHER THAN PRESCRIBERS NEED TO KNOW ABOUT ANTIPSYCHOTICS

Although prescribing antipsychotics for people with serious mental illness is the responsibility of psychiatrists and nurse practitioners, other members of the mental health team, such as therapists or care coordinators often have established relationships with clients that make them a go-to for questions or concerns about treatment. This training reviews the available antipsychotic medications, indications for use, symptom outcomes with treatment, and the differences between the various antipsychotics. The training will provide attendees a solid understanding of antipsychotic medications that clinicians can integrate into their current practices to promote improved health outcomes.

Intended Audience: Clinicians

CEU Credit(s): One (1) available for LCSWs, LCSW-Rs and LMSWs

Are Two Antipsychotics Better Than One?

The use of multiple antipsychotics is a too common practice in psychiatry today. This training reviews the data on adding a second antipsychotic to preexisting treatment with a single antipsychotic for inadequate symptom response and management of hyperprolactinemia. We will to review data on medication non-adherence, clozapine as the golden standard for treatment-resistant schizophrenia, and if and when adding a second antipsychotic is ever recommended in treatment.

Intended Audience: Prescribers

 

Long Acting Injectable Antipsychotics (LAIs)

LAIs and the Challenge of Medication Non-Adherence

This training provides information on how LAIs can be used as an intervention to address medication non-adherence. Participants will leave understanding the data on better outcomes for patients with long acting injectable antipsychotic (LAI) treatment and how use of LAIs facilitates clinical decision making.

Intended Audience: Prescribers, other clinicians and administrators

CEU Credit(s): One (1) available for LCSWs, LCSW-Rs and LMSWs

Helping Patients Make Decisions about LAI Treatment

Surveys show that most patients who might benefit by LAI treatment report never being informed of the option of LAI treatment. This training provides clinicians with the information they need to support patients and their families in making informed decisions about LAI treatment. Participants will leave with tactics for engaging patients in shared decision making as well as the properties of the LAIs currently available in the US.

Intended Audience: Prescribers, other clinicians

CEU Credit(s): One (1) available for LCSWs, LCSW-Rs and LMSWs

The Business of LAIs - Current Reimbursement for LAIs

This training addresses current reimbursement requirements for LAIs in New York State and procedures for the most efficient determination of coverage in order to implement an LAI program. Participants will leave the ability to navigate payer benefit and authorization policies.

Intended Audience: Administrators

Setting Up a LAI Program

The added requirements for providing LAIs are minimal for many clinics but differ from the requirements for providing oral medications. This training reviews the operational considerations providers must take into account when setting up an LAI program, including staffing, administration, scheduling, and supplies.

Intended Audience: Administrators

Switching Strategies, Dosing and Other Prescribing Issues

How do you determine if an LAI is the right fit for your patient, and if it is what is the best approach to transitioning medications? This training reviews key considerations for choosing and agent, strategies for switching and appropriately dosing medications. Participants will leave with the knowledge they need to safely transition their patients from oral or other injectable medications to the appropriate treatment.

Intended Audience: Prescribers

Sustaining a LAI program

This training addresses how enhancing LAI use can be part of overall clinical programs for medication adherence and for enhancing recovery. We will also discuss using data to document LAI benefits. Participants will learn how enhancing LAI use can be part of the overall clinical medication adherence programs and programs for enhancing recovery. By the end of this training, participants will also better, understand the data that indicates the benefits of LAIs.

Intended Audience: Administrators and clinicians

 

Clozapine

Using Data to Improve Patient Outcomes and Reduce Hospitalization Rates

Research suggests that use of long acting injectable medications and clozapine for people with serious mental illness is an important strategy to reduce the rate of relapse and, ultimately, re-hospitalization. Understanding your practice’s data is crucial for increasing the use of these treatment strategies, improving clinical outcomes and demonstrating to payers your use of evidence-based interventions for the populations you serve. This training will walk you through specific examples of using data to make practical decisions on the use of clozapine to improve the patient experience and prepare for the value based payment environment.

Intended Audience: Administrators and prescribers

First Steps for Considering Clozapine for Your Patients

Relapse episodes and hospitalizations are cost drivers that get special attention in a value-based payment environment. One important clinical basis for relapse and re-hospitalization is lack of response by many patients to their prescribed medications. Compared with other antipsychotics, clozapine has unique indications for use and can benefit patients who have had inadequate response to other antipsychotics. Despite these unique benefits, clozapine is underutilized, leading to potentially avoidable hospitalizations. This training will review the process of identifying which patients might benefit from clozapine treatment, as well as the associated workflow tasks for your organization.

Intended Audience: Administrators and prescribers

Engaging Patients and Families in Informed Decision-Making

Inadequate patient response to prescribed medications may lead to relapse and re-hospitalization, which drive up costs and undermine organizations’ success in a value-based payment environment. Compared to other antipsychotic medications, clozapine has unique indications for use and a unique side effect profile. Making the decision to try clozapine is a significant undertaking for patients and their supporters, as it requires a keen understanding of both the potential benefits and risks. It can therefore be challenging for clinicians to support patients as they make informed decisions about their use of clozapine. This training will equip treatment team members with the information necessary to facilitate informed decision-making.

Intended Audience: Prescribers, other clinicians

CEU Credit(s): One (1) available for LCSWs, LCSW-Rs and LMSWs

Clozapine Dosing and Side Effects Management – Part 1

Schizophrenia is a crippling condition with high rates of medication resistance. As many as 25-33% of patients diagnosed with schizophrenia experience an inadequate response to first-line antipsychotic drugs, resulting in avoidable relapse and hospitalizations. Clozapine is commonly known as the gold standard for treating refractory schizophrenia, yet it remains one of the most underutilized treatments due to safety concerns. Administration of clozapine demands careful medical supervision, but with proper monitoring, its side effects can be effectively managed. Reducing the burden of clozapine’s side effects leads to improved medication adherence and subsequently, better health outcomes. This training will address important considerations for properly dosing clozapine and strategies to reduce the burden of its associated side effects.

Intended Audience: Prescribers

Clozapine Dosing and Side Effects Management – Part 2

The second installment of this two-part training will address important considerations for detecting the side effects of clozapine, determining when side effects require discontinuation, and identifying when clozapine can be reinitiated post discontinuation. In order to effectively manage a patient’s treatment with clozapine, prescribers must be able to identify when side effects require clozapine discontinuation.

Intended Audience: Prescribers

The Care Transitions Network is made possible by a grant made to the National Council for Behavioral Health by the Centers for Medicare and Medicaid Services, in a partnership between the National Council, Montefiore Medical Center, Northwell Health (formerly North Shore-LIJ Health System), the New York State Office of Mental Health and Netsmart Technologies. Contact us by emailing CareTransitions@TheNationalCouncil.org or calling 202-849-4920. The project described was supported by Funding Opportunity Number CMS-1L1-15-003 from the U.S. Department of Health & Human Services, Centers for Medicare & Medicaid Services. Disclaimer: The contents provided are solely the responsibility of the authors and do not necessarily represent the official views of HHS or any of its agencies.
©2018 National Council for Behavioral Health. All Rights Reserved.